Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce (CELG-RI) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CELG-RI · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Bristol-Myers Squibb Company Ce insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
Recent insider transactions
CELG-RI executive sell shares · CELG-RI board member insider trading · CELG-RI insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 20, 2019 | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Award | 24,209 | — | Form 4 |
| Nov 20, 2019 | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Award | 13,906 | — | Form 4 |
| Nov 20, 2019 | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Award | 8,634 | — | Form 4 |
| Nov 20, 2019 | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Other | 613 | — | Form 4 |
| Nov 20, 2019 | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | Award | 17,840 | — | Form 4 |
| Nov 20, 2019 | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | Award | 8,035 | — | Form 4 |
| Nov 20, 2019 | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | Other | 1,966 | — | Form 4 |
| Nov 20, 2019 | Alles Mark J CEO, CHAIRMAN OF BOARD · Director | Award | 74,414 | — | Form 4 |
| Nov 20, 2019 | Alles Mark J CEO, CHAIRMAN OF BOARD · Director | Award | 45,119 | — | Form 4 |
| Nov 20, 2019 | Alles Mark J CEO, CHAIRMAN OF BOARD · Director | Award | 25,696 | — | Form 4 |
| Nov 20, 2019 | Alles Mark J CEO, CHAIRMAN OF BOARD · Director | Other | 6,252 | — | Form 4 |
| Nov 20, 2019 | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Award | 25,484 | — | Form 4 |
| Nov 20, 2019 | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Award | 11,088 | — | Form 4 |
| Nov 20, 2019 | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Award | 6,652 | — | Form 4 |
| Nov 20, 2019 | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Other | 195 | — | Form 4 |
| Nov 20, 2019 | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Award | 17,840 | — | Form 4 |
| Nov 20, 2019 | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Award | 9,889 | — | Form 4 |
| Nov 20, 2019 | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Award | 5,139 | — | Form 4 |
VESSEY RUPERT
PRES., RESEARCH AND EARLY DEV.
Date
Nov 20
Shares
24,209
Price
—
Value
—
VESSEY RUPERT
PRES., RESEARCH AND EARLY DEV.
Date
Nov 20
Shares
13,906
Price
—
Value
—
VESSEY RUPERT
PRES., RESEARCH AND EARLY DEV.
Date
Nov 20
Shares
8,634
Price
—
Value
—
VESSEY RUPERT
PRES., RESEARCH AND EARLY DEV.
Date
Nov 20
Shares
613
Price
—
Value
—
Alles Mark J
CEO, CHAIRMAN OF BOARD · Director
Date
Nov 20
Shares
74,414
Price
—
Value
—
Alles Mark J
CEO, CHAIRMAN OF BOARD · Director
Date
Nov 20
Shares
45,119
Price
—
Value
—
Alles Mark J
CEO, CHAIRMAN OF BOARD · Director
Date
Nov 20
Shares
25,696
Price
—
Value
—
Alles Mark J
CEO, CHAIRMAN OF BOARD · Director
Date
Nov 20
Shares
6,252
Price
—
Value
—
Elkins David V
EVP, CHIEF FINANCIAL OFFICER
Date
Nov 20
Shares
25,484
Price
—
Value
—
Elkins David V
EVP, CHIEF FINANCIAL OFFICER
Date
Nov 20
Shares
11,088
Price
—
Value
—
Elkins David V
EVP, CHIEF FINANCIAL OFFICER
Date
Nov 20
Shares
6,652
Price
—
Value
—
Elkins David V
EVP, CHIEF FINANCIAL OFFICER
Date
Nov 20
Shares
195
Price
—
Value
—
Curran Terrie
PRES., GLBL INFLAM. AND IMMUN.
Date
Nov 20
Shares
17,840
Price
—
Value
—
Curran Terrie
PRES., GLBL INFLAM. AND IMMUN.
Date
Nov 20
Shares
9,889
Price
—
Value
—
Curran Terrie
PRES., GLBL INFLAM. AND IMMUN.
Date
Nov 20
Shares
5,139
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CELG-RI insider trading
CELG-RI insider trades
Bristol-Myers Squibb Company Ce (CELG-RI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CELG-RI. Over the past 12 months, 0 insiders have filed transactions with the SEC. CELG-RI insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bristol-Myers Squibb Company Ce's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CELG-RI insider trading · 5 questionsThe insiders of Bristol-Myers Squibb Company Ce (CELG-RI) include executives and directors such as CELG-RI, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026